Cargando…
Left Ventricular Geometry and Blood Pressure as Predictors of Adverse Progression of Fabry Cardiomyopathy
BACKGROUND: In spite of several research studies help to describe the heart in Fabry disease (FD), the cardiomyopathy is not entirely understood. In addition, the impact of blood pressure and alterations in geometry have not been systematically evaluated. METHODS: In 74 FD patients (mean age 36±12 y...
Autores principales: | Krämer, Johannes, Bijnens, Bart, Störk, Stefan, Ritter, Christian O., Liu, Dan, Ertl, Georg, Wanner, Christoph, Weidemann, Frank |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4658091/ https://www.ncbi.nlm.nih.gov/pubmed/26600044 http://dx.doi.org/10.1371/journal.pone.0140627 |
Ejemplares similares
-
High‐Sensitivity Troponin: A Clinical Blood Biomarker for Staging Cardiomyopathy in Fabry Disease
por: Seydelmann, Nora, et al.
Publicado: (2016) -
Longitudinal strain bull’s eye plot patterns in patients with cardiomyopathy and concentric left ventricular hypertrophy
por: Liu, Dan, et al.
Publicado: (2016) -
Impact of Regional Left Ventricular Function on Outcome for Patients with AL Amyloidosis
por: Liu, Dan, et al.
Publicado: (2013) -
Potential role of vitamin D deficiency on Fabry cardiomyopathy
por: Drechsler, Christiane, et al.
Publicado: (2013) -
Long-term outcome of enzyme-replacement therapy in advanced Fabry disease: evidence for disease progression towards serious complications
por: Weidemann, F, et al.
Publicado: (2013)